for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

SBI Holdings Inc

8473.T

Latest Trade

2,924.00JPY

Change

-45.00(-1.52%)

Volume

1,606,300

Today's Range

2,921.00

 - 

3,020.00

52 Week Range

2,375.00

 - 

3,350.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
2,969.00
Open
2,971.00
Volume
1,606,300
3M AVG Volume
29.57
Today's High
3,020.00
Today's Low
2,921.00
52 Week High
3,350.00
52 Week Low
2,375.00
Shares Out (MIL)
244.89
Market Cap (MIL)
727,133.90
Forward P/E
7.20
Dividend (Yield %)
4.38

Next Event

Q3 2022 SBI Holdings Inc Earnings Release

Latest Developments

More

SBI Says To Extend Tob Period For Shinsei To Dec 10 From Dec 8

Murakami-Backed Fund City Index Eleventh Increases Stake In Shinsei Bank To 7.43% From 6.30% - Regulatory Filing

Japan's Shinsei says extending evaluation of SBI bid by 3 days

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About SBI Holdings Inc

SBI Holdings, Inc. is a Japan-based company mainly engaged in the financial business. The Company operates in three business segments. The Financial Service segment is engaged in the provision of financial products and related services focusing on securities, banks and insurance. The Asset Management segment includes investment business, overseas financial service business and asset management service business. The Bio-related segment is engaged in the development and sale of pharmaceuticals, health foods and cosmetics, as well as the operation of medical informatics business. The Company is also involved in the digital asset business, real estate business and renewable energy business, integrated non-fungible token (NFT) trading platform business.

Industry

Investment Services

Contact Info

19F, Izumi Garden Tower, 1-6-1, Roppongi

MINATO-KU, TKY

106-6019

Japan

+81.3.62290100

http://www.sbigroup.co.jp

Executive Leadership

Yoshitaka Kitao

President, Chief Executive Officer, Chairman & Chairman the Executive Board & Executive President of Subsidiaries, Representative Director

Katsuya Kawashima

Chief Operating Officer, Vice President, President & Executive President of Subsidiaries, Representative Director

Takashi Nakagawa

Vice President, Representative Director

Masato Takamura

Vice President, President of Subsidiaries, Representative Director

Shunpei Morita

Senior Managing Director

Key Stats

2.00 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2019

0.4K

2020

0.4K

2021

0.5K

2022(E)

0.6K
EPS (JPY)

2019

231.430

2020

163.180

2021

339.780

2022(E)

412.506
Price To Earnings (TTM)
6.74
Price To Sales (TTM)
1.12
Price To Book (MRQ)
1.20
Price To Cash Flow (TTM)
4.21
Total Debt To Equity (MRQ)
327.00
LT Debt To Equity (MRQ)
327.00
Return on Investment (TTM)
5.37
Return on Equity (TTM)
2.14

Latest News

Latest News

Japan's Shinsei Bank to withdraw poison pill defence against SBI Holdings' bid

Shinsei Bank said on Wednesday it will cancel plans to introduce a poison pill defence aimed at blocking SBI Holdings Inc's $1.1 billion bid, paving the way for the online financial conglomerate to take effective control of the lender.

Deposit Insurance Corp to oppose Shinsei's poison pill against SBI -NHK

Government-owned Deposit Insurance Corp of Japan (DICJ) is planning to vote against Shinsei Bank's poison pill defence aimed at blocking SBI Holdings Inc's $1.1 billion bid, public broadcaster NHK reported on Tuesday.

Japan's DIC to oppose Shinsei Bank's poison pill defence against SBI -NHK

Japan's Deposit Insurance Corp, one of Shinsei Bank's top shareholders, is planning to vote against the bank's poison pill defence against SBI Holdings Inc's takeover bid, public broadcaster NHK reported on Tuesday.

Japan's SBI to weigh Shinsei majority stake if tender offer succeeds

SBI Holdings Inc on Friday said it would consider taking a majority stake in Shinsei Bank Ltd if it succeeds in its $1.1 billion tender offer to raise its stake in the mid-sized lender to 48% from about 20%.

Shinsei Bank poison pill defence wins backing of another proxy adviser

Proxy advisory firm ISS followed rival Glass Lewis & Co in recommending shareholders of Japan's Shinsei Bank Ltd vote for the lender's plan for a poison pill defence against an unsolicited $1.1 billion bid from SBI Holdings Inc.

Shinsei Bank poison pill defence wins backing from another proxy advisory firm

U.S. proxy advisory firm ISS has joined Glass Lewis & Co in recommending shareholders of Japan's Shinsei Bank Ltd vote for the lender's plan for a poison pill defence against an unsolicited $1.1 billion bid from SBI Holdings Inc.

Japan's Shinsei Bank poison pill defence backed by proxy advisory firm

U.S. proxy advisory firm Glass Lewis & Co on Friday recommended shareholders of Japan's Shinsei Bank Ltd vote for the lender's plan for a poison pill defence against an unsolicited $1.1 billion bid from SBI Holdings Inc.

UPDATE 1-Amid takeover battle, SBI chief says Shinsei Bank lacks vision

SBI Holdings Inc's chief executive on Thursday accused Shinsei Bank's management of lacking a clear vision or philosophy as the online financial conglomerate aims to take effective control of the lender.

Japan's Shinsei outlines poison pill against SBI, offers 0.8 share

Japan's Shinsei Bank is offering 0.8 share for each share held by investors other than SBI Holdings Inc in a takeover defence against the rival's $1.1 billion tender offer bid, according to a filing with the Tokyo Stock Exchange on Thursday.

Japan's Shinsei to beef up Asian alliances in a takeover battle with SBI

Japan's Shinsei Bank plans to beef up its small-scale finance business in Asia Pacific through alliances and acquisitions as it scrambles to map out its own growth strategy to fend off SBI Holdings' $1.1 billion takeover bid.

Japan's SBI rejects new bid conditions sought by Shinsei Bank

SBI Holdings Inc on Thursday rejected new conditions requested for its bid to buy Shinsei Bank Ltd, including a demand that it pays more than the $1.1 billion in its existing offer and that it remove a share purchase limit.

Japan's Shinsei opposes SBI's $1.1 billion bid, sets conditions for support

Japan's Shinsei Bank Ltd said on Thursday it opposed SBI Holdings' $1.1 billion tender offer bid, but could support it if SBI removes the upper limit of its planned share purchases and increases its offer price.

UPDATE 2-Japan's Shinsei opposes SBI's $1.1 bln bid, sets conditions for support

Japan's Shinsei Bank Ltd said on Thursday it opposed SBI Holdings' $1.1 billion tender offer bid, but could support it if SBI removes the upper limit of its planned share purchases and increases its offer price.

Japan's Shinsei Bank to officially reject SBI's $1.1 billion - Nikkei

Japan's Shinsei Bank Ltd plans to officially reject SBI Holdings' $1.1 billion tender offer bid due to concerns that the rights of its shareholders could be infringed if SBI takes effective control, Nikkei reported on Monday.

Japan's Shinsei Bank forms independent panel to respond to SBI takeover bid

Japan's Shinsei Bank Ltd is forming a panel of independent directors to weigh its response to a takeover bid from SBI Holdings, so as to ensure the "fairness and objectivity of the evaluation," it said on Wednesday.

Japan's SBI extends tender offer period as requested by Shinsei Bank

Japan's SBI Holdings said on Wednesday it would extend the period of its $1.1 billion tender offer bid for Shinsei Bank Ltd to Dec. 8, acquiescing to the bank's request for a 60-day extension.

Japan's SBI to extend offer for Shinsei by a month on some conditions

Japanese financial conglomerate SBI Holdings said on Friday it would extend the deadline for its $1.1 billion unsolicited tender offer for Shinsei Bank to Nov. 24 from Oct. 25 if Shinsei agreed to meet certain conditions.

SBI to extend tender offer for Shinsei by a month on certain conditions

SBI Holdings said on Friday it would extend the deadline for its $1.1 billion tender offer to Nov. 24 from Oct. 25 for Shinsei Bank if Shinsei agrees to meet certain conditions.

Shinsei Bank to use poison-pill defence against SBI's $1.1 billion bid

Shinsei Bank's board has decided to use a poison-pill defence against an unsolicited $1.1 billion bid from shareholder SBI Holdings, the Japanese lender said on Friday, as it scrambles for ways to thwart the takeover.

Japan's SBI to fight Shinsei poison pill, reject bid delay -Nikkei

Japan's SBI Holdings plans to file an injunction against rival Shinsei Bank to block it from adopting a poison-pill defence against its $1.1-billion bid, the Nikkei financial daily said on Friday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up